# Biologics for Rheumatoid Arthritis Pain (BIORA-PAIN)

> **NCT04255134** · PHASE4 · COMPLETED · sponsor: **St George's, University of London** · enrollment: 18 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** Abatacept Injection
- **DRUG:** Adalimumab Injection

## Key facts

- **NCT ID:** NCT04255134
- **Lead sponsor:** St George's, University of London
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-09-07
- **Primary completion:** 2022-10-26
- **Final completion:** 2022-10-26
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2023-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04255134

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04255134, "Biologics for Rheumatoid Arthritis Pain (BIORA-PAIN)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04255134. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*